Loading clinical trials...
Loading clinical trials...
Multimodal Therapy With and Without Cetuximab in Patients With Locally Advanced Esophageal Carcinoma - An Open-Label Phase III Trial
Conditions
Interventions
cetuximab
cisplatin
+3 more
Locations
57
Austria
Landeskrankenhaus
Feldkirch, Austria
Universitätsklinik für Innere Medizin I
Innsbruck, Austria
Krankenhaus Barmherzige Schwestern Linz
Linz, Austria
Krankenhaus der Elisabethinen Linz GmbH
Linz, Austria
Universitätsklinikum der PMU Salzburg
Salzburg, Austria
Universitätsklinik für Innere Medizin
Vienna, Austria
Start Date
May 27, 2010
Primary Completion Date
October 6, 2016
Completion Date
December 9, 2018
Last Updated
October 20, 2020
NCT06713993
NCT06257264
NCT00242723
NCT06253871
NCT05005403
NCT04674267
Lead Sponsor
Swiss Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions